Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?

Marchlinski, Francis E; Oraii, Alireza; Muser, Daniele

Marchlinski, Francis E; Oraii, Alireza; Muser, Daniele.

Afiliação

Marchlinski FE; Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Pavilion, 2 City, 1 Convention Ave, Philadelphia, PA 19104, USA.
Oraii A; Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Pavilion, 2 City, 1 Convention Ave, Philadelphia, PA 19104, USA.
Muser D; Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Pavilion, 2 City, 1 Convention Ave, Philadelphia, PA 19104, USA.

Eur Heart J ; 45(1): 67-69, 2024 Jan 01.

Article em En | MEDLINE | ID: mdl-37995207

Assuntos

Fibrilação Atrial; Acidente Vascular Cerebral; Humanos; Fibrilação Atrial/complicações; Fibrilação Atrial/tratamento farmacológico; Acidente Vascular Cerebral/etiologia; Acidente Vascular Cerebral/prevenção & controle; Anticoagulantes/uso terapêutico; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Acidente Vascular Cerebral Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google